{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T08:34:59Z","timestamp":1784622899439,"version":"3.55.0"},"reference-count":38,"publisher":"SynthesisHub Advance Scientific Research","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiovascular Disease Research"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jcdr.2013.12.001","type":"journal-article","created":{"date-parts":[[2014,2,7]],"date-time":"2014-02-07T00:00:16Z","timestamp":1391731216000},"source":"Crossref","is-referenced-by-count":3,"title":["Patterns and determinants of cardiovascular drug utilization in coronary care unit patients of a tertiary care hospital"],"prefix":"10.31838","author":[{"given":"Jesso","family":"George","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmini","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak Y.","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6788-8185","authenticated-orcid":false,"given":"Naveen","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8021-0571","authenticated-orcid":false,"given":"Nitin S.","family":"Kunnoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra S.","family":"Sanil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17074","reference":[{"key":"10.1016\/j.jcdr.2013.12.001_bib1","series-title":"World Health Organization. Global Status Report of NCD 2010","author":"AlaAlwan","year":"2011"},{"key":"10.1016\/j.jcdr.2013.12.001_bib2","series-title":"Report on Causes of Death in India 2001\u20132003","author":"Registrar General of India","year":"2009"},{"key":"10.1016\/j.jcdr.2013.12.001_bib3","first-page":"495","article-title":"The global burden of disease in 1990: summary results, sensitivity analysis and future directions","volume":"72","author":"Murray","year":"1994","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jcdr.2013.12.001_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/hrt.2007.132951","article-title":"Epidemiology and causation of coronary heart disease and stroke in India","volume":"94","author":"Gupta","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.jcdr.2013.12.001_bib5","series-title":"Forecasting Vascular Disease Cases and Associated Mortality in India. Reports of the National Commission on Macroeconomics and Health","author":"Indrayan","year":"2005"},{"key":"10.1016\/j.jcdr.2013.12.001_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/157488607779315507","article-title":"Adverse drug reactions in hospitals: a narrative review","volume":"2","author":"Davies","year":"2007","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.jcdr.2013.12.001_bib7","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.jacc.2011.02.009","volume":"57","author":"Wright","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcdr.2013.12.001_bib8","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jcdr.2013.12.001_bib9","first-page":"57","article-title":"Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group","volume":"2","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jcdr.2013.12.001_bib10","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jcdr.2013.12.001_bib11","first-page":"161","article-title":"Treatment of acute myocardial infarction: does the type of hospital make a difference? PPAMI Study Group","volume":"51","author":"George","year":"1999","journal-title":"Indian Heart J"},{"key":"10.1016\/j.jcdr.2013.12.001_bib12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/1471-2458-10-358","article-title":"Use of evidence-based pharmacotherapy after myocardial infarction in Estonia","volume":"10","author":"Marandi","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jcdr.2013.12.001_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/1995-705X.76800","article-title":"The underutilization of adjunctive pharmacotherapy in treating acute coronary syndrome patients admitted to a tertiary care hospital in southwest region, Saudi Arabia","volume":"11","author":"Assiri","year":"2010","journal-title":"Heart Views"},{"key":"10.1016\/j.jcdr.2013.12.001_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00228-011-1138-9","article-title":"Patterns, predictors and preventability of adverse drug reactions in the coronary care unit of a tertiary care hospital","volume":"68","author":"Devi","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jcdr.2013.12.001_bib15","series-title":"WHO Collaborating Centre for Drug Statistics Methodology,Guidelines for ATC Classification and DDD Assignment, 2012","year":"2011"},{"key":"10.1016\/j.jcdr.2013.12.001_bib16","series-title":"Model Lists of Essential Medicines","author":"WHO","year":"2011"},{"key":"10.1016\/j.jcdr.2013.12.001_bib17","series-title":"International Classification of Diseases","author":"WHO","year":"2010"},{"key":"10.1016\/j.jcdr.2013.12.001_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ahj.2009.06.003","article-title":"The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes","volume":"158","author":"Goodman","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcdr.2013.12.001_bib19","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1093\/eurheartj\/ehl196","article-title":"The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004","volume":"27","author":"Mandelzweig","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcdr.2013.12.001_bib20","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(08)60623-6","article-title":"Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data","volume":"371","author":"Xavier","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jcdr.2013.12.001_bib21","first-page":"688","article-title":"Hypertension & pre-hypertension in developing countries","volume":"128","author":"Pradeepa","year":"2008","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jcdr.2013.12.001_bib22","unstructured":"The Global Burden. www.idf.org\/diabetesatlas\/5e\/the-global-burden. Accessed 22.04.13."},{"key":"10.1016\/j.jcdr.2013.12.001_bib23","first-page":"S3","article-title":"Reducing the global burden of blood pressure-related cardiovascular disease","volume":"18","author":"Rodgers","year":"2000","journal-title":"J\u00a0Hypertens Suppl"},{"key":"10.1016\/j.jcdr.2013.12.001_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jama.1997.03540280039031","article-title":"Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality","volume":"277","author":"Classen","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jcdr.2013.12.001_bib25","first-page":"3150","article-title":"Does the Pharmacological management of unstable angina vary with age and gender \u2013 a descriptive study","volume":"4","author":"Banerjee","year":"2010","journal-title":"J\u00a0Clin Diagnostic Res"},{"key":"10.1016\/j.jcdr.2013.12.001_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCULATIONAHA.107.188208","volume":"117","author":"King","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jcdr.2013.12.001_bib27","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcdr.2013.12.001_bib28","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s002280000226","article-title":"A\u00a0study of drug utilisation and cost of treatment in patients hospitalised with unstable angina","volume":"56","author":"Malhotra","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jcdr.2013.12.001_bib29","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(02)08265-X","article-title":"Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jcdr.2013.12.001_bib30","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1053\/euhj.2001.2896","article-title":"Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand","volume":"22","author":"Szwed","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcdr.2013.12.001_bib31","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/CIRCULATIONAHA.107.724880","volume":"116","author":"Scirica","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcdr.2013.12.001_bib32","doi-asserted-by":"crossref","first-page":"593S","DOI":"10.1378\/chest.08-0724","article-title":"Valvular and structural heart disease: American College of Chest physicians evidence-based clinical practice guidelines (8th Edition)","volume":"133","author":"Salem","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jcdr.2013.12.001_bib33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0272-6386(00)70018-7","article-title":"Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials","volume":"35","author":"Kshirsagar","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcdr.2013.12.001_bib34","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/S0272-6386(04)00369-5","article-title":"K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease","volume":"43","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcdr.2013.12.001_bib35","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1001\/jama.1988.03410140100032","article-title":"Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction","volume":"260","author":"Yusuf","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.jcdr.2013.12.001_bib36","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcdr.2013.12.001_bib37","first-page":"184","article-title":"Frontiers in congestive heart failure: effect of Metoprolol CR\/XL in chronic heart failure: metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"5","author":"Tepper","year":"1999","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.jcdr.2013.12.001_bib38","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1161\/CIRCULATIONAHA.109.192065","volume":"119","author":"Hunt","year":"2009","journal-title":"Circulation"}],"container-title":["Journal of Cardiovascular Disease Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T13:25:33Z","timestamp":1585229133000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0975358313001010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":38,"alternative-id":["S0975358313001010"],"URL":"https:\/\/doi.org\/10.1016\/j.jcdr.2013.12.001","relation":{},"ISSN":["0975-3583"],"issn-type":[{"value":"0975-3583","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}